Skip to main content
SpringerLink
Log in

Tacrolimus: In Heart Transplant Recipients

A Viewpoint by Nicholas R. Banner

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Banner NR, Lyster H, Yacoub MH. Clinical immunosuppression using the calcineurin-inhibitors ciclosporin and tacrolimus. In: Pinna LA, Cohen PTW, editors. Inhibitors of protein kinases and protein phosphates. Handbook of Experimental Pharmacology, Vol. 167. New York: Springer, 2005: 321–59

    Chapter  Google Scholar 

  2. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report, 2005. J Heart Lung Transplant 2005 Aug; 24(8): 945–55

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Consultant in Cardiology and Transplant Medicine, The Royal Brompton and Harefield NHS Trust, Harefield Hospital, Harefield, Middlesex, England

    Nicholas R. Banner

Authors
  1. Nicholas R. Banner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banner, N.R. Tacrolimus: In Heart Transplant Recipients. Drugs 66, 2280 (2006). https://doi.org/10.2165/00003495-200666170-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666170-00012

Search

Navigation